SCHEMBL6994828

SCHEMBL6994828

CC(=O)OCc1c(C)c(=O)n(C(C)=O)c2c(Cl)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 3/20 0.34
ALDH1A1 P00352 4/20 0.34
AKR1B1 P15121 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
ELANE P08246 1/20 0.33
NOTUM Q6P988 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
ABCB1 P08183 1/20 0.32
HTT P42858 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6994825 0.76 ALDH1A1 (0.41) LMNACYP1A2CYP2C9NPSR1KDM4E
SCHEMBL6998461 0.72 KDM4E (0.49) LMNASMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL1092493 0.72 ALDH1A1 (0.52) LMNASMN1; SMN2NPSR1KDM4EALDH1A1
SCHEMBL13034152 0.66 SMN1; SMN2 (0.57) LMNASMN1; SMN2CYP1A2CYP2C19ALDH1A1
SCHEMBL26741264 0.66 ALDH1A1 (0.44) LMNASMN1; SMN2KDM4EALDH1A1AKR1B1
SCHEMBL4647196 0.65 ALDH1A1 (0.61) LMNASMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL29853925 0.65 ALDH1A1 (0.61) LMNASMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL605494 0.64 ALDH1A1 (0.53) LMNASMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL30025953 0.64 ALDH1A1 (0.42) LMNASMN1; SMN2CYP3A4CYP2C9CYP2C19
SCHEMBL6837449 0.62 ALDH1A1 (0.47) KDM4EALDH1A1ELANEGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003724-B1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION AVENTIS PHARMA GMBH (DE) 2003-02-12 EP disclosed
EP-1003724-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION Aventis Pharma Deutschland GmbH (DE) 2000-05-31 EP disclosed
WO-1997037977-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION HOECHST AKTIENGESELLSCHAFT (DE) 1997-10-16 WO disclosed